Abstract
Sudden cardiac death (SCD) is a major cause of mortality in elderly individuals owing to a high prevalence of coronary heart disease, systolic dysfunction, and congestive heart failure (CHF). Although the incidence of SCD increases with age, the proportion of cardiac deaths that are sudden decreases owing to high numbers of other cardiac causes of death in elderly individuals. Implantable cardioverter-defibrillator (ICD) therapy has been demonstrated to improve survival and prevent SCD in selected patients with systolic dysfunction and CHF. However, ICD therapy in elderly patients might not be effective because of a greater rate of pulseless electrical activity underlying SCD and other competing nonarrhythmic causes of death in this population. Although under-represented in randomized trials of ICD use, elderly patients comprise a substantial proportion of the population that qualifies for and receives an ICD for primary prevention under current guidelines. Cardiac resynchronization therapy (CRT), which has been demonstrated to reduce mortality in selected populations with heart failure, is also more commonly used in this group of patients than in younger individuals. In this Review, we examine the causes of SCD in elderly individuals, and discuss the existing evidence for effectiveness of ICD therapy and CRT in this growing population.
Key Points
-
The incidence of sudden cardiac death (SCD) increases with age owing to increasing prevalence of coronary heart disease and congestive heart failure among elderly individuals
-
Elderly patients are more likely to have pulseless electrical activity or asystole at the time of SCD and are less likely to survive a cardiac arrest than younger individuals
-
The mortality benefit and cost-effectiveness of primary prevention implantable cardioverter-defibrillator (ICD) therapy in elderly patients is dependent on competing mortality risks and survival following device implantation
-
Cardiac resynchronization therapy (CRT) has demonstrated mortality and quality-of-life benefits across age groups
-
A substantial and growing proportion of primary prevention ICD and CRT devices are being implanted in elderly patients, and additional outcomes data in this growing population are needed
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lopshire, J. C. & Zipes, D. P. Sudden cardiac death: better understanding of risks, mechanisms, and treatment. Circulation 114, 1134–1136 (2006).
Zipes, D. P. et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114, e385–e484 (2006).
Fishman, G. I. et al. Sudden cardiac death prediction and prevention report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 122, 2335–2348 (2010).
Roger, V. L. et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 123, e18–e209 (2011).
Kong, M. H. et al. Systematic review of the incidence of sudden cardiac death in the United States. J. Am. Coll. Cardiol. 57, 794–801 (2011).
Josephson, M. & Wellens, H. J. Implantable defibrillators and sudden cardiac death. Circulation 109, 2685–2691 (2004).
Gillum, R. F. Geographic variation in sudden coronary death. Am. Heart J. 119, 380–389 (1990).
Myerburg, R. J. & Castellanos, A. in Cardiac Electrophysiology: From Cell to Bedside 5th edn Ch. 77 (eds Zipes, D. P. & Jalife, J.) 797–808 (Saunders Elsevier, Philadelphia, 2009).
Ford, E. S. et al. Explaining the decrease in, U.S. deaths from coronary disease, 1980–2000. N. Engl. J. Med. 356, 2388–2398 (2007).
Rosamond, W. D. et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N. Engl. J. Med. 339, 861–867 (1998).
Fox, C. S., Evans, J. C., Larson, M. G., Kannel, W. B. & Levy, D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 110, 522–527 (2004).
Zheng, Z. J., Croft, J. B., Giles, W. H. & Mensah, G. A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104, 2158–2163 (2001).
Dudas, K., Lappas, G., Stewart, S. & Rosengren, A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation 123, 46–52 (2011).
Gerber, Y. et al. Secular trends in deaths from cardiovascular diseases: a 25-year community study. Circulation 113, 2285–2292 (2006).
Chugh, S. S. et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large, U.S. community. J. Am. Coll. Cardiol. 44, 1268–1275 (2004).
Albert, C. M. et al. Prospective study of sudden cardiac death among women in the United States. Circulation 107, 2096–2101 (2003).
Sasson, C., Rogers, M. A., Dahl, J. & Kellermann, A. L. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes 3, 63–81 (2010).
Rothwell, P. M. et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366, 1773–1783 (2005).
Youngquist, S. T., Kaji, A. H. & Niemann, J. T. Beta-blocker use and the changing epidemiology of out-of-hospital cardiac arrest rhythms. Resuscitation 76, 376–380 (2008).
Teodorescu, C. et al. Survival advantage from ventricular fibrillation and pulseless electrical activity in women compared to men: the Oregon Sudden Unexpected Death Study. J. Interv. Card. Electrophysiol. 34, 219–225 (2012).
Teodorescu, C. et al. Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study. Circulation 122, 2116–2122 (2010).
Albert, C. M., McGovern, B. A., Newell, J. B. & Ruskin, J. N. Sex differences in cardiac arrest survivors. Circulation 93, 1170–1176 (1996).
Huikuri, H. V., Castellanos, A. & Myerburg, R. J. Sudden death due to cardiac arrhythmias. N. Engl. J. Med. 345, 1473–1482 (2001).
Priori, S. G. et al. Unexplained cardiac arrest. The need for a prospective registry. Eur. Heart J. 13, 1445–1446 (1992).
Chugh, S. S., Kelly, K. L. & Titus, J. L. Sudden cardiac death with apparently normal heart. Circulation 102, 649–654 (2000).
Bai, R., Napolitano, C., Bloise, R., Monteforte, N. & Priori, S. G. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ. Arrhythm. Electrophysiol. 2, 6–15 (2009).
Krahn, A. D. et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation 120, 278–285 (2009).
Tan, H. L., Hofman N., van Langen, I. M., van der Wal, A. C. & Wilde, A. A. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 112, 207–213 (2005).
Nannenberg, E. A. et al. Mortality of inherited arrhythmia syndromes: insight into their natural history. Circ. Cardiovasc. Genet. 5, 183–189 (2012).
Kannel, W. B., Cupples, L. A. & D'Agostino, R. B. Sudden death risk in overt coronary heart disease: the Framingham Study. Am. Heart J. 113, 799–804 (1987).
Cupples, L. A., Gagnon, D. R. & Kannel, W. B. Long- and short-term risk of sudden coronary death. Circulation 85, I11–I18 (1992).
Adelson, L. & Hoffman, W. Sudden death from coronary disease related to a lethal mechanism arising independently of vascular occlusion or myocardial damage. JAMA 176, 129–135 (1961).
Farb, A. et al. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 92, 1701–1709 (1995).
Greene, H. L. Sudden arrhythmic cardiac death--mechanisms, resuscitation and classification: the Seattle perspective. Am. J. Cardiol. 65, 4B–12B (1990).
Burke, A. P. et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N. Engl. J. Med. 336, 1276–1282 (1997).
Burke, A. P. et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 97, 2110–2116 (1998).
Solomon, S. D. et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N. Engl. J. Med. 352, 2581–2588 (2005).
Solomon, S. D. et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112, 3738–3744 (2005).
Bigger, J. T. Jr, Fleiss, J. L., Kleiger, R., Miller, J. P. & Rolnitzky, L. M. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69, 250–258 (1984).
Kannel, W. B., Plehn, J. F. & Cupples, L. A. Cardiac failure and sudden death in the Framingham Study. Am. Heart J. 115, 869–875 (1988).
Roger, V. L. et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292, 344–350 (2004).
Chen, J., Normand S. L., Wang, Y. & Krumholz, H. M. National and regional trends in heart failure hospitalization and mortality rates for medicare beneficiaries, 1998–2008. JAMA 306, 1669–1678 (2011).
Curtis, L. H. et al. Incidence and Prevalence of Heart Failure in Elderly Persons, 1994–2003 Arch. Intern. Med. 168, 418–24 (2008).
Lloyd-Jones, D. M. et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106, 3068–3072 (2002).
Krahn, A. D., Connolly, S. J., Roberts, R. S., Gent, M. & ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am. Heart J. 147, 837–840 (2004).
[No authors listed] Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353, 2001–2007 (1999).
Owan, T. E. et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355, 251–259 (2006).
Al-Khatib, S. M., Shaw, L. K., O'Connor, C., Kong, M. & Califf, R. M. Incidence and predictors of sudden cardiac death in patients with diastolic heart failure. J. Cardiovasc. Electrophysiol. 18, 1231–1235 (2007).
Henkel, D. M., Redfield, M. M., Weston, S. A., Gerber, Y. & Roger, V. L. Death in heart failure: a community perspective. Circ. Heart Fail. 1, 91–97 (2008).
van Rees, J. B. et al. Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace 14, 66–73 (2012).
Rea, T. D., Eisenberg, M. S., Sinibaldi, G. & White, R. D. Incidence of EMS-treated out-of-hospital cardiac arrest in the United States. Resuscitation 63, 17–24 (2004).
Herlitz, J., Eek, M., Engdahl, J., Holmberg, M. & Holmberg, S. Factors at resuscitation and outcome among patients suffering from out of hospital cardiac arrest in relation to age. Resuscitation 58, 309–317 (2003).
Herlitz, J. et al. Experiences from treatment of out-of-hospital cardiac arrest during 17 years in Goteborg. Eur. Heart J. 21, 1251–1258 (2000).
Herlitz, J. et al. Characteristics of cardiac arrest and resuscitation by age group: an analysis from the Swedish Cardiac Arrest Registry. Am. J. Emerg. Med. 25, 1025–1031 (2007).
Kitamura, T. et al. Nationwide improvements in survival from out-of-hospital cardiac arrest in Japan. Circulation 126, 2834–2843 (2012).
Moss, A. J. et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med. 335, 1933–1940 (1996).
Moss, A. J. et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346, 877–883 (2002).
Bardy, G. H. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225–237 (2005).
Kadish, A. et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med. 350, 2151–2158 (2004).
Buxton, A. E. et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med. 341, 1882–1890 (1999).
National Coverage Determination (NCD) for Implantable Automatic Defibrillators (20.4). Centers for Medicare & Medicaid Services [online], (2005).
Bigger, J. T. Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N. Engl. J. Med. 337, 1569–1575 (1997).
Steinbeck, G. et al. Defibrillator implantation early after myocardial infarction. N. Engl. J. Med. 361, 1427–1436 (2009).
Hohnloser, S. H. et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med. 351, 2481–2488 (2004).
Buxton, A. E. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation 111, 2537–2549 (2005).
Chugh, S. S. et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog. Cardiovasc. Dis. 51, 213–228 (2008).
Stecker, E. C. et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J. Am. Coll. Cardiol. 47, 1161–1166 (2006).
Chugh, S. S. et al. Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest: The Ore-SUDS (Oregon Sudden Unexpected Death Study). J. Am. Coll. Cardiol. 54, 2006–2011 (2009).
Stevenson, L. W. Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: are there enough bangs for the bucks? Circulation 114, 101–103 (2006).
Mark, D. B. et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 114, 135–142 (2006).
Sanders, G. D., Hlatky, M. A. & Owens, D. K. Cost-effectiveness of implantable cardioverter-defibrillators. N. Engl. J. Med. 353, 1471–1480 (2005).
Epstein, A. E. et al. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm 5, 934–955 (2008).
McClellan, M. B. & Tunis, S. R. Medicare coverage of ICDs. N. Engl. J. Med. 352, 222–224 (2005).
Santangeli, P. et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann. Intern. Med. 153, 592–599 (2010).
Huang, D. T. et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J. Cardiovasc. Electrophysiol. 18, 833–838 (2007).
Epstein, A. E. et al. Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm 6, 1136–1143 (2009).
Tsai, V. et al. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ. Cardiovasc. Qual. Outcomes 4, 549–556 (2011).
Mezu, U., Adelstein, E., Jain, S. & Saba, S. Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death. Am. J. Cardiol. 108, 718–722 (2011).
Chan, P. S. et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ. Cardiovasc. Qual. Outcomes 2, 16–24 (2009).
Curtis, L. H. et al. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 298, 1517–1524 (2007).
Geelen, P., Lorga Filho, A., Primo, J., Wellens, F. & Brugada, P. Experience with implantable cardioverter defibrillator therapy in elderly patients. Eur. Heart J. 18, 1339–1342 (1997).
Lee, D. S. et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J. Am. Coll. Cardiol. 49, 2408–2415 (2007).
Panotopoulos, P. T. et al. Efficacy of the implantable cardioverter-defibrillator in the elderly. J. Am. Coll. Cardiol. 29, 556–560 (1997).
Pellegrini, C. N. et al. Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace 10, 1296–1301 (2008).
Quan, K. J. et al. Favorable results of implantable cardioverter-defibrillator implantation in patients older than 70 years. Ann. Thorac. Surg. 64, 1713–1717 (1997).
Trappe, H. J., Pfitzner, P., Achtelik, M. & Fieguth, H. G. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period. Heart 78, 364–370 (1997).
Duray, G. et al. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J. Interv. Card. Electrophysiol. 14, 169–173 (2005).
Sanders, G. D., Kong, M. H., Al-Khatib, S. M. & Peterson, E. D. Cost-effectiveness of implantable cardioverter defibrillators in patients >or = 65 years of age. Am. Heart J. 160, 122–131 (2010).
Zwanziger, J. et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J. Am. Coll. Cardiol. 47, 2310–2318 (2006).
St John Sutton, M. G. et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107, 1985–1990 (2003).
Cazeau, S. et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 344, 873–880 (2001).
Young, J. B. et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289, 2685–2694 (2003).
Higgins, S. L. et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J. Am. Coll. Cardiol. 42, 1454–1459 (2003).
Cleland, J. G. et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352, 1539–1549 (2005).
Bristow, M. R. et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350, 2140–2150 (2004).
Cleland, J. G. et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur. Heart J. 27, 1928–1932 (2006).
Moss, A. J. et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 361, 1329–1338 (2009).
Tang, A. S. et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med. 363, 2385–2395 (2010).
Hara, H. et al. The relationship of QRS morphology and mechanical dyssynchrony to long-term outcome following cardiac resynchronization therapy. Eur. Heart J. 33, 2680–2691 (2012).
Sipahi, I. et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am. Heart J. 163, 260–267 (2012).
Nery, P. B., Ha, A. C., Keren, A. & Birnie, D. H. Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: a systematic review. Heart Rhythm 8, 1083–1087 (2011).
Bilchick, K. C., Kamath, S., DiMarco, J. P. & Stukenborg, G. J. Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients. Circulation 122, 2022–2030 (2010).
Tracy, C. M. et al. ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 126, 1784–1800 (2012).
Swindle, J. P., Rich, M. W., McCann, P., Burroughs, T. E. & Hauptman, P. J. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch. Intern. Med. 170, 631–637 (2010).
Author information
Authors and Affiliations
Contributions
P. Tung researched the data and wrote the article. C. M. Albert substantially contributed to reviewing and editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
C. M. Albert declares that she has received a research grant from St Jude Medical to study markers of sudden cardiac death in patients with coronary artery disease. P. Tung declares no competing interests.
Rights and permissions
About this article
Cite this article
Tung, P., Albert, C. Causes and prevention of sudden cardiac death in the elderly. Nat Rev Cardiol 10, 135–142 (2013). https://doi.org/10.1038/nrcardio.2012.201
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2012.201
This article is cited by
-
Differences in clinical characteristics in patients with first ST-segment elevation myocardial infarction and ventricular fibrillation according to sex
Journal of Interventional Cardiac Electrophysiology (2017)
-
Ventricular arrhythmias and the His–Purkinje system
Nature Reviews Cardiology (2016)